Helex is a US and India-based early preclinical biotechnology company developing genomic medicines for high-burden kidney diseases
Helex is a US and India-based early preclinical biotechnology company developing genomic medicines for high-burden kidney diseases. Their proprietary lipid nanoparticle technology enables targeted delivery of therapeutic cargo, and their pioneering Epic-Cure™ technology ensures de-risked drug design for greater precision and safety of genetic medicines.